从药物基因组学知识获取到临床应用:PharmGKB 作为临床药物基因组学生物标志物资源。

From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.

机构信息

Department of Genetics, Stanford University, 1501 S California Avenue, Palo Alto, CA 94304, USA.

出版信息

Biomark Med. 2011 Dec;5(6):795-806. doi: 10.2217/bmm.11.94.

Abstract

The mission of the Pharmacogenomics Knowledge Base (PharmGKB; www.pharmgkb.org ) is to collect, encode and disseminate knowledge about the impact of human genetic variations on drug responses. It is an important worldwide resource of clinical pharmacogenomic biomarkers available to all. The PharmGKB website has evolved to highlight our knowledge curation and aggregation over our previous emphasis on collecting primary data. This review summarizes the methods we use to drive this expanded scope of 'Knowledge Acquisition to Clinical Applications', the new features available on our website and our future goals.

摘要

Pharmacogenomics Knowledge Base(PharmGKB;www.pharmgkb.org)的使命是收集、编码和传播有关人类遗传变异对药物反应影响的知识。它是全球范围内可供所有人使用的临床药物基因组生物标志物的重要资源。PharmGKB 网站的发展重点已经从之前的收集原始数据转变为突出我们的知识管理和整合。本综述总结了我们用于推动这一“从知识获取到临床应用”扩展范围的方法、我们网站上提供的新功能以及我们的未来目标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索